2013
DOI: 10.1007/s40256-013-0052-1
|View full text |Cite
|
Sign up to set email alerts
|

Management of Microvascular Angina Pectoris

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
4

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 79 publications
0
17
0
4
Order By: Relevance
“…Furthermore, evaluating vasoconstriction at the epicardial level only is insufficient to accurately determine CBF and diagnose endothelial dysfunction(29,30). Thus, the current study supports the need for an assessment of microvascular function in patients referred for coronary angiography and the need to directly quantify CBF to confirm or refute a diagnosis of microvascular endothelial dysfunction, particularly as potential treatments for microvascular dysfunction are evolving(31).This study also extends the findings of Ong et al(32), in which 24.2% of patients with nonobstructive CAD had microvascular endothelial dysfunction, defined as a reproduction of the patient's angina and ischemic electrocardiographic ST segment changes.…”
mentioning
confidence: 53%
“…Furthermore, evaluating vasoconstriction at the epicardial level only is insufficient to accurately determine CBF and diagnose endothelial dysfunction(29,30). Thus, the current study supports the need for an assessment of microvascular function in patients referred for coronary angiography and the need to directly quantify CBF to confirm or refute a diagnosis of microvascular endothelial dysfunction, particularly as potential treatments for microvascular dysfunction are evolving(31).This study also extends the findings of Ong et al(32), in which 24.2% of patients with nonobstructive CAD had microvascular endothelial dysfunction, defined as a reproduction of the patient's angina and ischemic electrocardiographic ST segment changes.…”
mentioning
confidence: 53%
“…Пациенты с МСС имеют высокую резистентность к устоявшейся антиангинальной терапии, которая часто не способна купировать и снизить частоту ангинозных присту-пов, а также недостаточно предотвращает прогрессирование симптомов заболевания [41]. В многочисленных работах подчеркивается, что среди всех антиангинальных препара-тов самая высокая эффективность доказана для бета-блока-торов [42,43].…”
Section: рисунок 1 патогенез микрососудистой стенокардии [22]unclassified
“…VMD patofiziologiniai struktūriniai ir funkciniai mechanizmai yra įvairūs, apima vaskulinį ir ekstravaskulinį lygmenis [10] 1. Nėra pastovios ir nuoseklios koreliacijos tarp VA stenozių dydžio ir išemijos bei KA.…”
Section: Literatūros Apžvalgaunclassified
“…Tačiau pristatomu atveju skausmas priekinėje krūtinės ląstos dalyje nebuvo tipiškas, o tai literatūroje vadinama VMD specifika [10]:…”
Section: Pav Elektrokardiograma Pakartotino Vizito Pas Kardiologą Metuunclassified
See 1 more Smart Citation